Focus Stocks
Omnicare Booked a New High
Published on Thursday, 01 December 2011 12:34 Written by Christian Paolinetti
New York, December 1st (TradersHuddle.com) - Shares of Omnicare, Inc. (NYSE:OCR) booked a new 52 week high today by trading above $33.01, traders are definitely monitoring Omnicare's price action to see if this move attracts further buying into the stock.
Omnicare, Inc. (NYSE:OCR), based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities, chronic care and other settings in 47 states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Its pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare also offers clinical research services for the pharmaceutical and biotechnology industries in 31 countries worldwide.
Omnicare is currently trading 0.61% versus its previous trading session close, and it has calculated support and resistance at $29.16 and $31.38 respectively. Clearly with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range
The overall market index S&P 500 is trading lower by -0.2% from its previous trading close, which means that Omnicare stock is outperforming the overall market.
Related Articles
- Bulls in Charge of Omnicare
- Omnicare: Waiting for Direction
- Critical Alerts For Coca-Cola, Caterpillar, Omnicare, United Continental, and Allscripts Healthcare Solutions By Seven Summits Research
- Omnicare Higher With High Volume
- Candlesticks - Bearish Engulfing Omnicare
- PharMerica Comments on Omnicare’s Decision to Allow Its Unsolicited Tender Offer to Expire
- Omnicare Near the 50 Day
- Up/Downgrades ( ES, FIO, FOSL, OCR, SWY, KMB, ARB, HAS, EW, IHG )
- Omnicare Expecting Resistance Soon?
Related Partner Headlines
- Omnicare Inc (OCR): Today's Featured Wholesale Loser - TheStreet.com
- Omnicare Inc (OCR): Today's Featured Wholesale Loser - TheStreet.com
- Omnicare Inc (OCR): Today's Featured Wholesale Loser - TheStreet.com
- Omnicare Stock Hits New 52-Week High (OCR) - TheStreet.com
- Omnicare Rises On Unusually High Volume (OCR) - TheStreet.com
- Omnicare Adopts Rule 10b5-1 Plan in Conjunction with Share Repurchase Program - Benzinga
- Omnicare Stock To Go Ex-dividend Tomorrow (OCR) - TheStreet.com
- Omnicare Announces Additional Share Repurchase Authorization and Increase to Quarterly Cash Dividend by 75% - Benzinga
- PharMerica Comments on Omnicare's Decision to Allow Its Unsolicited Tender Offer to Expire - Benzinga
- UPDATE: Omnicare Announces Expiration of Its Tender Offer to Acquire PharMerica - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
In Facebook's Manipulated IPO, Only Insiders Win - TheStreet.com -
2 Stocks to Avoid on the Dead Cat Bounce - TheStreet.com -
Euro Fears Drive U.S. Bank Downgrades - TheStreet.com -
JPMorgan Is a 'Absolute Buy': Citigroup - TheStreet.com -
Barclays Quits BlackRock - TheStreet.com -
Barclays to Sell .1B BlackRock Stake: Hot Trends - TheStreet.com -
Facebook, Nasdaq and Yahoo!: Pre-Market Movers - TheStreet.com -
Day Ahead: Searching for Dying Roots - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,408.66 Trade time:10:08AM EDT Value change:▲39.28 (0.32%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,300.15 Trade time:10:08AM EDT Value change:▲4.93 (0.38%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,789.98 Trade time:10:08AM EDT Value change:▲11.19 (0.40%)In The Wires
-
Alice P. Frazier Named to ICBA Board of Directors -
Reis, Inc. to Present at B. Riley & Co. 13th Annual Investor Conference -
Anaren, Inc. to Participate in the KeyBanc Capital Markets Industrial, Automotive & Transportation Conference -
Kiwa Bio-Tech First Quarter Results Announced -
Guidestar Announces Partnership With MobileCause -
U.S. Homeownership Aspirations Aren't Dead: Owning a Home Remains a Defining Element of the American Dream -
Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London -
Camelot Inks Two Picture Deal With National Lampoon









